Actively Recruiting
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Led by Ain Shams University · Updated on 2025-04-09
42
Participants Needed
2
Research Sites
89 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.
CONDITIONS
Official Title
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children and adolescents aged from 2 to 18 years
- Newly diagnosed with acute lymphoblastic leukemia
- Currently in the induction phase of chemotherapy
- Treated at Ain Shams
You will not qualify if you...
- Known chronic liver disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Ain Shams University
Cairo, Egypt, 11566
Actively Recruiting
2
Faculty of Medicine Ain Shams Research Institute- Clinical Research Center (MASRI-CRC)
Cairo, Egypt, 11566
Actively Recruiting
Research Team
F
Fatma S E Ebeid, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here